Federal contract award
75N95025P00265
INDI ALFATAG CELL LINES FOR THE IPSC NEURODEGENETIVE DISEASE INITIATIVE (INDI) PROJECT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.5M |
| Current contract value | $1.5M |
| Potential contract value / ceiling | $1.5M |
| Start date | Aug 1, 2025 |
| Current end date | Jul 31, 2026 |
| Potential end date | Jul 31, 2026 |
| Latest award activity | May 8, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 8, 2025 | 0 | $1.5M | INDI ALFATAG CELL LINES FOR THE IPSC NEURODEGENETIVE DISEASE INITIATIVE (INDI) PROJECT |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.